| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 201.55B | 189.42B | 165.51B | 183.22B | 163.67B | 133.54B |
| Gross Profit | 85.81B | 85.37B | 72.50B | 88.19B | 74.94B | 56.67B |
| EBITDA | 64.08B | 64.97B | 55.70B | 65.64B | 59.56B | 45.70B |
| Net Income | 30.26B | 33.03B | 26.48B | 34.65B | 31.44B | 19.92B |
Balance Sheet | ||||||
| Total Assets | 427.83B | 416.87B | 403.45B | 401.36B | 394.78B | 370.50B |
| Cash, Cash Equivalents and Short-Term Investments | 86.34B | 85.67B | 90.34B | 88.03B | 68.39B | 57.84B |
| Total Debt | 6.07B | 5.20B | 5.93B | 5.48B | 4.97B | 4.40B |
| Total Liabilities | 50.20B | 45.90B | 38.76B | 50.97B | 52.15B | 43.83B |
| Stockholders Equity | 377.63B | 370.15B | 364.17B | 349.85B | 342.07B | 326.09B |
Cash Flow | ||||||
| Free Cash Flow | 26.29B | 29.00B | 8.98B | 27.14B | 30.47B | 21.92B |
| Operating Cash Flow | 47.85B | 55.68B | 41.05B | 45.65B | 44.32B | 35.82B |
| Investing Cash Flow | -11.16B | -42.95B | -13.94B | 6.40B | -10.88B | -20.70B |
| Financing Cash Flow | -32.42B | -16.67B | -28.19B | -34.17B | -25.25B | -9.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥411.76B | 9.21 | 11.96% | 3.04% | 2.70% | ― | |
78 Outperform | ¥679.46B | 15.50 | 8.07% | 2.85% | 11.18% | -0.75% | |
74 Outperform | ¥6.47T | 59.16 | 8.95% | 1.88% | 2.88% | 28.76% | |
74 Outperform | ¥67.27B | 12.79 | ― | 2.20% | 4.75% | 164.54% | |
67 Neutral | ¥3.88T | 15.03 | ― | 1.41% | 7.73% | -1.93% | |
64 Neutral | ¥154.35B | 29.59 | 5.91% | 2.39% | -3.24% | -25.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |